111 related articles for article (PubMed ID: 2501594)
21. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
Young MR; Wright MA
Cancer Res; 1992 Nov; 52(22):6335-40. PubMed ID: 1423279
[TBL] [Abstract][Full Text] [Related]
22. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
23. Existence of a threshold-like dose for gamma-ray induction of thymic lymphomas and no susceptibility to radiation-induced solid tumors in SCID mice.
Ishii-Ohba H; Kobayashi S; Nishimura M; Shimada Y; Tsuji H; Sado T; Ogiu T
Mutat Res; 2007 Jun; 619(1-2):124-33. PubMed ID: 17397880
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming.
Romieu-Mourez R; François M; Abate A; Boivin MN; Birman E; Bailey D; Bramson JL; Forner K; Young YK; Medin JA; Galipeau J
Cancer Res; 2010 Oct; 70(20):7742-7. PubMed ID: 20924101
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
Talmadge JE; Tribble HR; Pennington RW; Phillips H; Wiltrout RH
Cancer Res; 1987 May; 47(10):2563-70. PubMed ID: 3105865
[TBL] [Abstract][Full Text] [Related]
26. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
[TBL] [Abstract][Full Text] [Related]
27. A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.
Briscoe H; Roach DR; Meadows N; Rathjen D; Britton WJ
J Leukoc Biol; 2000 Oct; 68(4):538-44. PubMed ID: 11037976
[TBL] [Abstract][Full Text] [Related]
28. Decreased incidence of thymic lymphoma in AKR mice as a result of chronic, fractionated low-dose total-body X irradiation.
Ishii K; Hosoi Y; Yamada S; Ono T; Sakamoto K
Radiat Res; 1996 Nov; 146(5):582-5. PubMed ID: 8896586
[TBL] [Abstract][Full Text] [Related]
29. ras oncogenes and phenotypic staging in N-methylnitrosourea- and gamma-irradiation-induced thymic lymphomas in C57BL/6J mice.
Newcomb EW; Steinberg JJ; Pellicer A
Cancer Res; 1988 Oct; 48(19):5514-21. PubMed ID: 3046741
[TBL] [Abstract][Full Text] [Related]
30. A new locus for resistance to gamma-radiation-induced thymic lymphoma identified using inter-specific consomic and inter-specific recombinant congenic strains of mice.
Santos J; Montagutelli X; Acevedo A; López P; Vaquero C; Fernández M; Arnau MR; Szatanik M; Salido E; Guénet JL; Fernández-Piqueras J
Oncogene; 2002 Sep; 21(43):6680-3. PubMed ID: 12242666
[TBL] [Abstract][Full Text] [Related]
31. Cellular events during radiation-induced thymic leukemogenesis in mice: abnormal T cell differentiation in the thymus and defect of thymocyte precursors in the bone marrow after split-dose irradiation.
Muto M; Kubo E; Sado T
J Immunol; 1985 Mar; 134(3):2026-31. PubMed ID: 3871460
[TBL] [Abstract][Full Text] [Related]
32. Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in gamma-radiation-induced mouse primary thymic lymphomas.
Santos J; Pérez de Castro I; Herranz M; Pellicer A; Fernández-Piqueras J
Oncogene; 1996 Feb; 12(3):669-76. PubMed ID: 8637724
[TBL] [Abstract][Full Text] [Related]
33. [Lympho-epithelial interactions in the thymus during development of radio-induced lymphomas in C57BL mice].
Houben-Defresne MP; Lenaerts P; Greimers R; Boniver J
C R Seances Soc Biol Fil; 1984; 178(2):195-202. PubMed ID: 6235898
[TBL] [Abstract][Full Text] [Related]
34. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
35. [Relations between the capacity of thymic repeopling and the formation of lymphoma obtained by radiation-induced preleukemic cells in C57BL/Ka mice].
Rongy AM; Defresne MP; Greimers R; Humblet C; Boniver J
C R Seances Soc Biol Fil; 1987; 181(1):88-93. PubMed ID: 2954627
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity on chromosome 5 in vicinity of the telomere in gamma-radiation-induced thymic lymphomas in mice.
Sitarz M; Wirth-Dzieciolowska E; Demant P
Neoplasma; 2000; 47(3):148-50. PubMed ID: 11043836
[TBL] [Abstract][Full Text] [Related]
37. Characterization of preneoplastic thymocytes and of their neoplastic progression in irradiated C57BL/Ka mice.
Sen-Majumdar A; Guidos C; Kina T; Lieberman M; Weissman IL
J Immunol; 1994 Aug; 153(4):1581-92. PubMed ID: 8046233
[TBL] [Abstract][Full Text] [Related]
38. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
[TBL] [Abstract][Full Text] [Related]
39. Radiation-induced incidence of thymic lymphoma in mice and its prevention by antioxidants.
Dange P; Sarma H; Pandey BN; Mishra KP
J Environ Pathol Toxicol Oncol; 2007; 26(4):273-9. PubMed ID: 18197825
[TBL] [Abstract][Full Text] [Related]
40. A protective role of 13-cis retinoic acid in thymic lymphoma induction.
Przybyszewska M
Arch Immunol Ther Exp (Warsz); 1985; 33(6):811-5. PubMed ID: 3868963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
